Wei-Min Tong Selected Research

Wei-Min Tong Research Topics

Disease

20	Neoplasms (Cancer) 02/2023 - 02/2002
6	Carcinogenesis 10/2022 - 04/2004
3	Adenocarcinoma 01/2023 - 08/2020
3	Infections 12/2022 - 11/2003
3	Medulloblastoma 10/2022 - 01/2003
3	Breast Neoplasms (Breast Cancer) 01/2021 - 08/2007
3	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2019 - 05/2005
3	Genomic Instability 04/2014 - 12/2002
3	Liver Neoplasms (Liver Cancer) 01/2013 - 12/2002
3	Chromosomal Instability (Chromosome Stability) 12/2010 - 04/2003
2	Pancreatic Neoplasms (Pancreatic Cancer) 02/2023 - 01/2021
2	COVID-19 01/2022 - 12/2020
2	Pituitary Neoplasms (Pituitary Adenoma) 01/2022 - 01/2020
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2020
2	Nijmegen Breakage Syndrome 04/2014 - 08/2006
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2005 - 02/2002
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2003 - 12/2002
1	Mitochondrial Encephalomyopathies (Mitochondrial Encephalomyopathy) 01/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2023
1	Viral Encephalitis 12/2022
1	Glioma (Gliomas) 04/2022
1	Glioblastoma (Glioblastoma Multiforme) 04/2022
1	Hypoxia (Hypoxemia) 04/2022
1	Growth Hormone-Secreting Pituitary Adenoma 01/2022
1	Lymphatic Metastasis 01/2021
1	Ependymoma 01/2020
1	Microcephaly 01/2014
1	Hepatocellular Carcinoma (Hepatoma) 12/2010
1	Cataract (Cataracts) 08/2006
1	Keratoacanthoma 12/2005
1	Papilloma (Papillomatosis) 12/2005
1	Chromosome Breakage 05/2005
1	Shock 08/2004
1	Endometrioid Carcinoma 04/2004
1	Endometrial Neoplasms (Endometrial Cancer) 04/2004
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 11/2003
1	Glucagonoma 09/2003
1	Gastrinoma 09/2003
1	Insulinoma 08/2003

Drug/Important Bio-Agent (IBA)

8	DNA (Deoxyribonucleic Acid)IBA 04/2022 - 12/2002
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2002
5	6-methyladenineIBA 10/2022 - 01/2020
5	5-hydroxymethylcytosineIBA 04/2022 - 01/2020
3	RNA (Ribonucleic Acid)IBA 04/2022 - 01/2021
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2020
3	A-Form DNA (A-DNA)IBA 04/2014 - 08/2006
3	Poly (ADP-Ribose) Polymerase-1IBA 08/2007 - 04/2004
2	Hormones (Hormone)IBA 01/2022 - 09/2003
2	Indicators and Reagents (Reagents)IBA 01/2021 - 02/2002
2	beta CateninIBA 08/2003 - 12/2002
2	Cadherins (E-Cadherin)IBA 08/2003 - 12/2002
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2003 - 12/2002
1	CateninsIBA 02/2023
1	Glutamine (L-Glutamine)FDA Link 02/2023
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2023
1	AntioxidantsIBA 01/2023
1	Mitochondrial DNA (mtDNA)IBA 01/2023
1	GlycosyltransferasesIBA 01/2023
1	Neuropilin-1IBA 12/2022
1	Bacterial DNAIBA 04/2022
1	5-Methylcytosine (5 Methylcytosine)IBA 04/2022
1	NucleosidesIBA 04/2022
1	Biocompatible Materials (Biomaterials)IBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Growth Hormone (Somatotropin)IBA 01/2022
1	MethyltransferasesIBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	N-methyladenosineIBA 01/2022
1	IronIBA 01/2021
1	InterferonsIBA 12/2020
1	MucinsIBA 12/2020
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 12/2020
1	Vitamin D3 24-HydroxylaseIBA 08/2020
1	Vitamin D FDA LinkGeneric 08/2020
1	Phenobarbital (Luminal)FDA Link 01/2020
1	Phosphotransferases (Kinase)IBA 01/2019
1	Protein Kinases (Protein Kinase)IBA 01/2019
1	ParaffinIBA 04/2014
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2014
1	NestinIBA 01/2014
1	TOR Serine-Threonine KinasesIBA 01/2014
1	NucleotidesIBA 07/2013
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 01/2013
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 12/2010
1	PoisonsIBA 12/2010
1	Protein Isoforms (Isoforms)IBA 12/2010
1	ChromatinIBA 12/2010
1	poly ADP-ribose glycohydrolaseIBA 12/2010
1	Codon (Codons)IBA 03/2007
1	Valine (L-Valine)FDA Link 03/2007
1	Alanine (L-Alanine)FDA Link 03/2007
1	Aflatoxin B1 (Aflatoxin B)IBA 08/2006
1	CarcinogensIBA 12/2005
1	Streptozocin (Streptozotocin)FDA Link 08/2004
1	Progesterone Receptors (Progesterone Receptor)IBA 04/2004
1	Immunoglobulin E (IgE)IBA 11/2003
1	Immunoglobulin G (IgG)IBA 11/2003
1	Complementary DNA (cDNA)IBA 11/2003

Therapy/Procedure

3	Therapeutics 01/2023 - 08/2007
1	Lenses 08/2006